3-(3-Chloropropanamido)phenyl 3-chloropropanoate

Catalog No. :
ACHZWX397
CAS No. :
2250243-33-3
Molecular Formula :
C12H13Cl2NO3
Molecular Weight :
290.15

IUPAC Name:3-(3-chloropropanamido)phenyl 3-chloropropanoate

3-(3-Chloropropanamido)phenyl 3-chloropropanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$136.00Login to see priceInquiryInquiry
250mg97%$233.00Login to see priceInquiryInquiry
1g97%$629.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-Chloropropanamido)phenyl 3-chloropropanoate
IUPAC Name3-(3-chloropropanamido)phenyl 3-chloropropanoate
MDL No.MFCD32220337
Molecular FormulaC12H13Cl2NO3
Molecular Weight290.15
SMILESO=C(OC1=CC=CC(NC(CCCl)=O)=C1)CCCl
InChI KeyWHOCEENAVAJUSX-UHFFFAOYSA-N
SynonymAripiprazole-002;3-(3-Chloropropanamido)phenyl 3-Chloropropanoate;Propanoic acid, 3-chloro-, 3-[(3-chloro-1-oxopropyl)amino]phenyl ester
CAS No.2250243-33-3
PubChem CID138109310

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHZWX397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMSQF359 route compound structure diagram
    ACMSQF35950297-40-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHZWX397 route product structure diagram
    ACHZWX3972250243-33-3
Inquiry

2. ACHZWX397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMSQF359 route compound structure diagram
    ACMSQF35950297-40-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHZWX397 route product structure diagram
    ACHZWX3972250243-33-3
Inquiry

Comments (0)